130 related articles for article (PubMed ID: 38197091)
1. Short-Term Outcomes of COVID-19 Pandemic on Non-Small Cell Lung Cancer Screening and Management.
Orelaru F; Edwards M; Raleigh R; Abunayla A; Bush R; Porter S; Schumaker K; Albright J; Adams KN
Surg J (N Y); 2023 Oct; 9(4):e156-e161. PubMed ID: 38197091
[No Abstract] [Full Text] [Related]
2. Real-World Evidence of the Impact of the COVID-19 Pandemic on Lung Cancer Survival: Canadian Perspective.
Agulnik J; Kasymjanova G; Pepe C; Friedmann J; Small D; Sakr L; Wang H; Spatz A; Sultanem K; Cohen V
Curr Oncol; 2024 Mar; 31(3):1562-1571. PubMed ID: 38534952
[No Abstract] [Full Text] [Related]
3. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Garassino MC; Whisenant JG; Huang LC; Trama A; Torri V; Agustoni F; Baena J; Banna G; Berardi R; Bettini AC; Bria E; Brighenti M; Cadranel J; De Toma A; Chini C; Cortellini A; Felip E; Finocchiaro G; Garrido P; Genova C; Giusti R; Gregorc V; Grossi F; Grosso F; Intagliata S; La Verde N; Liu SV; Mazieres J; Mercadante E; Michielin O; Minuti G; Moro-Sibilot D; Pasello G; Passaro A; Scotti V; Solli P; Stroppa E; Tiseo M; Viscardi G; Voltolini L; Wu YL; Zai S; Pancaldi V; Dingemans AM; Van Meerbeeck J; Barlesi F; Wakelee H; Peters S; Horn L;
Lancet Oncol; 2020 Jul; 21(7):914-922. PubMed ID: 32539942
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal Cancer Stage at Diagnosis Before and During the COVID-19 Pandemic in Japan.
Kuzuu K; Misawa N; Ashikari K; Kessoku T; Kato S; Hosono K; Yoneda M; Nonaka T; Matsushima S; Komatsu T; Nakajima A; Higurashi T
JAMA Netw Open; 2021 Sep; 4(9):e2126334. PubMed ID: 34546368
[TBL] [Abstract][Full Text] [Related]
5. The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Stage III Non-Small Cell Lung Cancer Patients Treated With Curative Chemoradiation.
Dieleman E; van der Woude L; van Os R; van Bockel L; Coremans I; van Es C; De Jaeger K; Knol HP; Kolff W; Koppe F; Pomp J; Reymen B; Schinagl D; Spoelstra F; Tissing-Tan C; van der Voort van Zyp N; van der Wel A; Wijsman R; Dielwart M; Wiegman E; Damhuis R; Belderbos J
Clin Lung Cancer; 2023 Mar; 24(2):130-136. PubMed ID: 36572596
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of pembrolizumab for advanced nonsmall cell lung cancer: before and during the COVID-19 pandemic.
Ksienski D; Gupta S; Truong PT; Bone J; Chan A; Alex D; Hart J; Pollock P; Patterson T; Clarkson M; Dissanayake D; Sonke E; Lesperance M
J Cancer Res Clin Oncol; 2023 Jul; 149(7):2951-2961. PubMed ID: 35834010
[TBL] [Abstract][Full Text] [Related]
7. Review of Lung Cancer Patient Characteristics and Treatment Strategies in the Pandemic Covid-19 Year.
Crvenkova S; Jakimovki D; Ristovski V
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2023 Mar; 44(1):105-115. PubMed ID: 36987767
[No Abstract] [Full Text] [Related]
8. Report on lung cancer surgery during COVID-19 pandemic at a high volume US institution.
Dolan DP; Lee DN; Polhemus E; Kucukak S; De León LE; Wiener D; Jaklitsch MT; Swanson SJ; White A
J Thorac Dis; 2022 Aug; 14(8):2874-2879. PubMed ID: 36071771
[TBL] [Abstract][Full Text] [Related]
9. Impact of COVID-19 Pandemic on Non-Small Cell Lung Cancer Care.
Zhai Y; Chopra P; Kang D; Robert NJ; Zhang W
Curr Oncol; 2023 Jan; 30(1):769-785. PubMed ID: 36661708
[TBL] [Abstract][Full Text] [Related]
10. Collateral effects of the coronavirus disease 2019 pandemic on lung cancer diagnosis in Korea.
Park JY; Lee YJ; Kim T; Lee CY; Kim HI; Kim JH; Park S; Hwang YI; Jung KS; Jang SH
BMC Cancer; 2020 Oct; 20(1):1040. PubMed ID: 33121456
[TBL] [Abstract][Full Text] [Related]
11. Endovascular stent grafting and open surgical replacement for chronic thoracic aortic aneurysms: a systematic review and prospective cohort study.
Sharples L; Sastry P; Freeman C; Gray J; McCarthy A; Chiu YD; Bicknell C; McMeekin P; Vallabhaneni SR; Cook A; Vale L; Large S
Health Technol Assess; 2022 Jan; 26(6):1-166. PubMed ID: 35094747
[TBL] [Abstract][Full Text] [Related]
12. Analyzing the impact of the Coronavirus disease 2019 pandemic on initial oncologic presentation and treatment of non-small cell lung cancer in the United States.
Dyas AR; Bronsert MR; Stuart CM; Thomas MB; Schulick RD; Franco SR; Gleisner A; Randhawa SK; David EA; Mitchell JD; Meguid RA
J Thorac Cardiovasc Surg; 2023 Nov; ():. PubMed ID: 37981103
[TBL] [Abstract][Full Text] [Related]
13. Delayed visit and treatment of lung cancer during the coronavirus disease 2019 pandemic in Japan: a retrospective study.
Terashima T; Tsutsumi A; Iwami E; Kuroda A; Nakajima T; Eguchi K
J Int Med Res; 2022 May; 50(5):3000605221097375. PubMed ID: 35579175
[TBL] [Abstract][Full Text] [Related]
14. Association of Receipt of Positron Emission Tomography-Computed Tomography With Non-Small Cell Lung Cancer Mortality in the Veterans Affairs Health Care System.
Vella M; Meyer CS; Zhang N; Cohen BE; Whooley MA; Wang S; Hope MD
JAMA Netw Open; 2019 Nov; 2(11):e1915828. PubMed ID: 31747036
[TBL] [Abstract][Full Text] [Related]
15. Major Pulmonary Resection for Non-Small Cell Lung Carcinoma during the COVID-19 Pandemic-Single Israeli Center Cross-Sectional Study.
Peer M; Azzam S; Kolodii M; Abramov Y; Shaylor R; Verenkin V; Nesher N; Matot I
J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207376
[TBL] [Abstract][Full Text] [Related]
16. First-line osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer: efficacy and safety during the COVID-19 pandemic.
Lakkunarajah S; Truong PT; Bone JN; Hughesman C; Yip S; Alex D; Hart J; Pollock P; Egli S; Clarkson M; Lesperance M; Ksienski D
Transl Lung Cancer Res; 2023 Jul; 12(7):1454-1465. PubMed ID: 37577326
[TBL] [Abstract][Full Text] [Related]
17. The Impact of COVID-19 Pandemic on Surgical Treatment of Resectable Non-Small Cell Lung Cancer in Greece.
Tomos I; Kapetanakis EI; Dimakopoulou K; Raptakis T; Kampoli K; Karakatsani A; Koumarianou A; Papiris S; Tomos P
Life (Basel); 2023 Jan; 13(1):. PubMed ID: 36676167
[TBL] [Abstract][Full Text] [Related]
18. Patterns of Pretreatment Diagnostic Assessment in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC): Special Characteristics in the COVID Pandemic and Influence on Outcomes.
Habermann FOJ; Schmitt D; Failing T; Fischer J; Ziegler DA; Fischer LA; Alt NJ; Muster J; Donath S; Hille A; Schirmer MA; Guhlich M; El Shafie RA; Rieken S; Leu M; Dröge LH
Curr Oncol; 2022 Feb; 29(2):1080-1092. PubMed ID: 35200591
[TBL] [Abstract][Full Text] [Related]
19. Impact of the COVID-19 Pandemic on Outcomes for Patients with Lung Cancer Receiving Curative-intent Radiotherapy in the UK.
Fornacon-Wood I; Banfill K; Ahmad S; Britten A; Carson C; Dorey N; Hatton M; Hiley C; Thippu Jayaprakash K; Jegannathen A; Kidd AC; Koh P; Panakis N; Peedell C; Peters A; Pope A; Powell C; Stilwell C; Thomas B; Toy E; Wicks K; Wood V; Yahya S; Price G; Faivre-Finn C
Clin Oncol (R Coll Radiol); 2023 Oct; 35(10):e593-e600. PubMed ID: 37507280
[TBL] [Abstract][Full Text] [Related]
20. Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global Pandemic.
Kumar S; Chmura S; Robinson C; Lin SH; Gadgeel SM; Donington J; Feliciano J; Stinchcombe TE; Werner-Wasik M; Edelman MJ; Moghanaki D
J Thorac Oncol; 2020 Jul; 15(7):1137-1146. PubMed ID: 32360578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
